- Home
- CYRX vs ETON Comparison
CYRX vs ETON Comparison
Compare CYRX & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYRX | ETON |
|---|---|---|
| Founded | 1999 | 2017 |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.6M | 411.9M |
| IPO Year | 2008 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CYRX | ETON |
|---|---|---|
| Price | $8.05 | $16.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $12.94 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 341.9K | 298.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 156.22 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $176,177,000.00 | $39,011,000.00 |
| Revenue This Year | $9.71 | $107.23 |
| Revenue Next Year | $9.56 | $29.72 |
| P/E Ratio | $4.99 | ★ N/A |
| Revenue Growth | N/A | ★ 23.29 |
| 52 Week Low | $4.63 | $11.09 |
| 52 Week High | $11.45 | $23.00 |
Technical Indicators
Market Signals| Indicator | CYRX | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 37.26 | 49.63 |
| Support Level | $6.57 | $16.04 |
| Resistance Level | $8.45 | $17.59 |
| Average True Range (ATR) | 0.51 | 1.05 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 25.71 | 6.21 |
Price Performance
Historical ComparisonAbout CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.